Browsing by Author González Barca, Eva
Showing results 1 to 11 of 11
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Oct-2002 | CD38 expression in B-cell chronic lymphoytic leukemia: association with clinical presentation and outcome in 155 patients | Domingo Domènech, Eva; Domingo-Clarós, Alicia; González Barca, Eva; Beneitez, David; Alonso Sanz, Esther; Romagosa, Vicenç; Sanjosé Llongueras, Silvia de; Petit Sullà, José María; Grañena Batista, Alberto; Fernández de Sevilla Ribosa, Alberto |
| 14-Nov-2013 | Clinical characteristics and risk of relapse for patients with stage I-II diffuse large B cell lymphoma treated in first line with immunochemotherapy | Mercadal, S.; Climent, F.; Domingo Domènech, Eva; Oliveira, A.; Romagosa, Vicenç; Fernández de Sevilla Ribosa, Alberto; González Barca, Eva |
| 1-Nov-2002 | Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas | Domingo Domènech, Eva; González Barca, Eva; Estany, Carla; Sureda, Anna; Besalduch, Joan; Fernández de Sevilla Ribosa, Alberto |
| 20-May-2021 | Consumption of Ultra-Processed Food and Drinks and Chronic Lymphocytic Leukemia in the MCC-Spain Study | Solans, Marta; Fernández Barrés, Sílvia; Romaguera, Dora; Benavente, Yolanda; Marcos Gragera, Rafael; Gracia Lavedan, Esther; Costas, Laura; Robles, Claudia; González Barca, Eva; Banda, Esmeralda de la; Alonso Sanz, Esther; Aymerich Gregorio, Marta; Campo Güerri, Elias; Llorca, Javier; Fernández Tardón, Guillermo; Olmedo Requena, Rocío; Gimeno, Eva; Castaño-Vinyals, Gemma; Aragonès Sanz, Núria; Kogevinas, Manolis; Pollán, Marina; Sanjosé Llongueras, Silvia de; Amiano, Pilar; Casabonne, Delphine |
| 14-Jan-2022 | Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial | Giné Soca, Eva; Cruz, Fátima de la; Jiménez Ubieto, Ana; López Jimenez, Javier; Martín García-Sancho, Alejandro; Terol, M. José; González Barca, Eva; Casanova, María; Fuente, Adolfo de la; Marín Niebla, Ana; Muntañola, Ana; González López, Tomás José; Aymerich Gregorio, Marta; Setoain Perego, Xavier; Cortés Romera, Montserrat; Rotger, Amanda; Rodríguez, Sonia; Medina Herrera, Alejandro; García Sanz, Ramón; Nadeu, Ferran; Beà Bobet, Sílvia M.; Campo Güerri, Elias; López Guillermo, Armando; The GELTAMO Group |
| 1-Jul-2021 | Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma | Duell, Johannes; Maddocks, Kami J.; González Barca, Eva; Jurczak, Wojciech; Liberati, Anna Marina; Vos, Sven de; Nagy, Zsolt; Obr, Aleš; Gaidano, Gianluca; Abrisqueta Costa, Pau; Kalakonda, Nagesh; André, Marc; Dreyling, Martin; Menne, Tobias; Tournilhac, Olivier; Augustin, Marinela; Rosenwald, Andreas; Dirnberger-Hertweck, Maren; Weirather, Johannes; Ambarkhane, Sumeet; Salles, Gilles |
| 2011 | Multiple platform assessmant of the EGF dependent transcritpome by microarrays and deep TAG sequencing analysis | Llorens Torres, Franc; Hummel, Manuela; Pastor Durán, Xavier; Ferrer, Anna; Pluvinet Ortega, Raquel; Vivancos, Ana; Castillo, Ester; Iraola Guzmán, Susana; Mosquera, Ana M.; González Barca, Eva; Lozano Salvatella, Juan José; Ingham, Matthew; Dohm, Juliane C.; Noguera, Marc; Kofler, Robert; Río Fernández, José Antonio del; Bayés Colomer, Mònica; Himmelbauer, Heinz; Sumoy, Lauro |
| 1-Jan-2013 | MYC protein expression and genetic alterations have prognostic impact in diffuse large B-cell lymphoma treated with immunochemotherapy | Valera Barros, Alexandra; López Guillermo, Armando; Cardesa Salzmann, Antonio; Climent, Fina; González Barca, Eva; Mercadal, Santiago; Espinosa, Iñigo; Novelli, Silvana; Briones, Javier; Mate, José L.; Salamero, Olga; Sancho, Juan Manuel; Arenillas Rocha, Leonor; Serrano, Sergi; Erill, Nadina; Martínez, Daniel; Castillo, Paola; Rovira, Jordina; Martínez, Antonio; Campo Güerri, Elias; Colomo Saperas, Lluís |
| 1-Aug-2014 | Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis | Montes Moreno, Santiago; Batlle, Ana; González de Villambrosía, Sonia; Sánchez-Espiridión, Beatriz; Cereceda, Laura; González Barca, Eva; Purroy, Noelia; Pardal, Emilia; Martín, Alejandro; Grande, Carlos; Mazorra, Francisco; Insunza, Andrés; Quero, Cristina; Aguiar, David; Cruz, Miguel Ángel; Rueda Dominguez, Antonio; Llanos, Marta; Gómez Codina, Jose; García Arroyo, Francisco Ramón; Caballero, Dolores; Conde, Eulogio; López, Andres; Provencio, Mariano; Piris, Miguel A. |
| 10-Feb-2016 | Targeting prohibitins induces apoptosis in acute myeloid leukemia cells | Pomares, Helena; Palmeri, Claudia Mariela; Iglesias i Serret, Daniel; Moncunill Massaguer, Cristina; Saura-Esteller, José; Núñez-Vázquez, Sonia; Gamundi, Enric; Arnan, Montserrat; Preciado Gallego, Sara; Albericio Palomera, Fernando; Lavilla Grífols, Rodolfo; Pons i Irazazábal, Gabriel; González Barca, Eva; Cosialls Castel, Ana Mª; Gil i Santano, Joan |
| 3-Mar-2021 | The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting | Condom, Maria; Mussetti, Alberto; Maluquer, Clara; Parody, Rocío; González Barca, Eva; Arnan, Montserrat; Albasanz Puig, Adaia; Pomares, Helena; Salas, Maria Queralt; Carro, Itziar; Peña, Marta; Clapes, Victòria; Baca Cano, Cristina; Oliveira Ramos, Ana Carla; Sanz Linares, Gabriela; Moreno González, Gabriel; Mercadal, Santiago; Boqué Genovard, Concepción; Gudiol González, Carlota; Domingo Domènech, Eva; Sureda, Anna |